INSANE: Concentra | Rare Historical Photos

Why Concentra’s Quiet Healthcare Business Keeps Winning

Concentra's Q2 revenue and profit beat estimates, and all eight analysts rate it a Buy, but a leadership transition and a 75% stock rally raise valuation questions.

MarketBeat · Oct 2

In-Depth Examination Of 4 Analyst Recommendations For Select Medical Hldgs

Select Medical Hldgs (NYSE:SEM) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Benzinga · Nov 25, 2024

Planned $425m merger under threat after rival's 'unsolicited' takeover bid

The merger was originally expected to be completed in the coming months

Birmingham Post · Mar 15, 2023